Literature DB >> 23661295

Functional studies of N-terminally modified CYP2J2 epoxygenase in model lipid bilayers.

Daniel R McDougle1, Amrita Palaria, Eric Magnetta, Daryl D Meling, Aditi Das.   

Abstract

CYP2J2 epoxygenase is a membrane bound cytochrome P450 that converts omega-3 and omega-6 fatty acids into physiologically active epoxides. In this work, we present a comprehensive comparison of the effects of N-terminal modifications on the properties of CYP2J2 with respect to the activity of the protein in model lipid bilayers using Nanodiscs. We demonstrate that the complete truncation of the N-terminus changes the association of this protein with the E.coli membrane but does not disrupt incorporation in the lipid bilayers of Nanodiscs. Notably, the introduction of silent mutations at the N-terminus was used to express full length CYP2J2 in E. coli while maintaining wild-type functionality. We further show that lipid bilayers are essential for the productive use of NADPH for ebastine hydroxylation by CYP2J2. Taken together, it was determined that the presence of the N-terminus is not as critical as the presence of a membrane environment for efficient electron transfer from cytochrome P450 reductase to CYP2J2 for ebastine hydroxylation in Nanodiscs. This suggests that adopting the native-like conformation of CYP2J2 and cytochrome P450 reductase in lipid bilayers is essential for effective use of reducing equivalents from NADPH for ebastine hydroxylation.
© 2013 The Protein Society.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23661295      PMCID: PMC3719090          DOI: 10.1002/pro.2280

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  79 in total

1.  Redox potential control by drug binding to cytochrome P450 3A4.

Authors:  Aditi Das; Yelena V Grinkova; Stephen G Sligar
Journal:  J Am Chem Soc       Date:  2007-10-19       Impact factor: 15.419

2.  Protein structure prediction on the Web: a case study using the Phyre server.

Authors:  Lawrence A Kelley; Michael J E Sternberg
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

Review 3.  Substrate binding to cytochromes P450.

Authors:  Emre M Isin; F Peter Guengerich
Journal:  Anal Bioanal Chem       Date:  2008-07-13       Impact factor: 4.142

4.  Bacterial expression and purification of interleukin-2 tyrosine kinase: single step separation of the chaperonin impurity.

Authors:  Raji E Joseph; Amy H Andreotti
Journal:  Protein Expr Purif       Date:  2008-04-11       Impact factor: 1.650

5.  Selective inhibitors of CYP2J2 related to terfenadine exhibit strong activity against human cancers in vitro and in vivo.

Authors:  Chen Chen; Guiling Li; Wanmin Liao; Jun Wu; Liu Liu; Ding Ma; Jianfeng Zhou; Reem H Elbekai; Matthew L Edin; Darryl C Zeldin; Dao Wen Wang
Journal:  J Pharmacol Exp Ther       Date:  2009-03-16       Impact factor: 4.030

6.  Effects of N-terminal modification of recombinant human cytochrome P450 1A2 on catalytic activity.

Authors:  H-J Kim; S-B Lee; F P Guengerich; Y I Park; M-S Dong
Journal:  Xenobiotica       Date:  2007-04       Impact factor: 1.908

7.  Heterologous expression and characterization of wild-type human cytochrome P450 1A2 without conventional N-terminal modification in Escherichia coli.

Authors:  Dong-Hyun Kim; Keon-Hee Kim; Emre M Isin; F Peter Guengerich; Ho Zoon Chae; Taeho Ahn; Chul-Ho Yun
Journal:  Protein Expr Purif       Date:  2007-10-22       Impact factor: 1.650

8.  Determinants of cytochrome P450 2C8 substrate binding: structures of complexes with montelukast, troglitazone, felodipine, and 9-cis-retinoic acid.

Authors:  Guillaume A Schoch; Jason K Yano; Stefaan Sansen; Patrick M Dansette; C David Stout; Eric F Johnson
Journal:  J Biol Chem       Date:  2008-04-15       Impact factor: 5.157

9.  Screening of type I and II drug binding to human cytochrome P450-3A4 in nanodiscs by localized surface plasmon resonance spectroscopy.

Authors:  Aditi Das; Jing Zhao; George C Schatz; Stephen G Sligar; Richard P Van Duyne
Journal:  Anal Chem       Date:  2009-05-15       Impact factor: 6.986

10.  Cytochrome p450 epoxygenase promotes human cancer metastasis.

Authors:  Jian-Gang Jiang; Yao-Gui Ning; Chen Chen; Ding Ma; Zhen-Jun Liu; Shilin Yang; Jianfeng Zhou; Xiao Xiao; Xin A Zhang; Matthew L Edin; Jeffrey W Card; Jianing Wang; Darryl C Zeldin; Dao Wen Wang
Journal:  Cancer Res       Date:  2007-07-15       Impact factor: 12.701

View more
  17 in total

Review 1.  Hydrogen-deuterium exchange mass spectrometry of membrane proteins in lipid nanodiscs.

Authors:  Michelle Redhair; Amanda F Clouser; William M Atkins
Journal:  Chem Phys Lipids       Date:  2019-02-22       Impact factor: 3.329

Review 2.  Nanodiscs in Membrane Biochemistry and Biophysics.

Authors:  Ilia G Denisov; Stephen G Sligar
Journal:  Chem Rev       Date:  2017-02-08       Impact factor: 60.622

3.  Cyclooxygenase-2 catalysis and inhibition in lipid bilayer nanodiscs.

Authors:  Benjamin J Orlando; Daniel R McDougle; Michael J Lucido; Edward T Eng; Leigh Ann Graham; Claus Schneider; David L Stokes; Aditi Das; Michael G Malkowski
Journal:  Arch Biochem Biophys       Date:  2014-02-03       Impact factor: 4.013

4.  Arachidonic Acid Metabolism by Human Cardiovascular CYP2J2 Is Modulated by Doxorubicin.

Authors:  William R Arnold; Javier L Baylon; Emad Tajkhorshid; Aditi Das
Journal:  Biochemistry       Date:  2017-12-12       Impact factor: 3.162

5.  Endocannabinoids anandamide and 2-arachidonoylglycerol are substrates for human CYP2J2 epoxygenase.

Authors:  Daniel R McDougle; Amogh Kambalyal; Daryl D Meling; Aditi Das
Journal:  J Pharmacol Exp Ther       Date:  2014-10-02       Impact factor: 4.030

6.  Heterologous expression and characterization of plant Taxadiene-5α-Hydroxylase (CYP725A4) in Escherichia coli.

Authors:  John Edward Rouck; Bradley Walters Biggs; Amogh Kambalyal; William R Arnold; Marjan De Mey; Parayil Kumaran Ajikumar; Aditi Das
Journal:  Protein Expr Purif       Date:  2017-01-18       Impact factor: 1.650

Review 7.  Recent advances in nanodisc technology for membrane protein studies (2012-2017).

Authors:  John E Rouck; John E Krapf; Jahnabi Roy; Hannah C Huff; Aditi Das
Journal:  FEBS Lett       Date:  2017-07-06       Impact factor: 4.124

8.  Assembly of phospholipid nanodiscs of controlled size for structural studies of membrane proteins by NMR.

Authors:  Franz Hagn; Mahmoud L Nasr; Gerhard Wagner
Journal:  Nat Protoc       Date:  2017-12-07       Impact factor: 13.491

9.  Endocannabinoid Virodhamine Is an Endogenous Inhibitor of Human Cardiovascular CYP2J2 Epoxygenase.

Authors:  Lauren N Carnevale; Andres S Arango; William R Arnold; Emad Tajkhorshid; Aditi Das
Journal:  Biochemistry       Date:  2018-11-06       Impact factor: 3.162

10.  Incorporation of charged residues in the CYP2J2 F-G loop disrupts CYP2J2-lipid bilayer interactions.

Authors:  Daniel R McDougle; Javier L Baylon; Daryl D Meling; Amogh Kambalyal; Yelena V Grinkova; Jared Hammernik; Emad Tajkhorshid; Aditi Das
Journal:  Biochim Biophys Acta       Date:  2015-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.